TY  - CONF

T1  - 55 Dupilumab treatment normalizes skin barrier function and improves patient-reported outcomes in patients aged 6 to 11 years with moderate-to-severe atopic dermatitis

JO  - Journal of Investigative Dermatology

UR  - http://dx.doi.org/10.1016/j.jid.2023.09.063

PY  - 2023/11/01

AU  - Cork MJ

AU  - Leung DYM

AU  - Ong P

AU  - Danby SG

AU  - Ramirez-Gama M

AU  - Garcia S

AU  - Taylor P

AU  - Zahn J

AU  - Praestgaard A

AU  - Bologna G

AU  - Zhang A

ED  - 

DO  - DOI: 10.1016/j.jid.2023.09.063

PB  - Elsevier BV

VL  - 143

IS  - 11

SP  - S342

EP  - S342

Y2  - 2024/12/22

ER  -